FDA Approves Everolimus for Liver Rejection – MedPage Today
 MedPage Today |
FDA Approves Everolimus for Liver Rejection
MedPage Today Despite the similarity in generic names, everolimus and tacrolimus are in different drug classes. Whereas everolimus is an mTOR inhibitor (similar to sirolimus, also known as rapamycin and sold as Rapamune), tacrolimus is a calcineurin inhibitor. Novartis’ Zortress cleared by FDA for liver transplantsPMLiVE Novartis drug Zortress is first in over a decade approved by FDA to prevent …PipelineReview.com (press release) FDA approves Zortress to prevent liver transplant rejectionHealio PharmaTimes –Pharmaceutical Business Review all 6 news articles » |
